![](https://www.wallstreetreporter.com/wp-content/uploads/2019/01/Cytodyn-Logo-326x238.png)
Newsmakers
CytoDyn (OTC: CYDY) to Deliver Presentation at Biotech Showcase Conference
BLA update and major licensing initiatives in cancer and immunology VANCOUVER, Washington, Jan 08, 2019- CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that […]